Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic cancer: Stroma and its current and emerging targeted therapies
Janaiah Kota, Julie Hancock, Jason J. Kwon, et al.
Cancer Letters (2017) Vol. 391, pp. 38-49
Closed Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

A Systematic Review of miR-29 in Cancer
Jason J. Kwon, Tricia D. Factora, Shatovisha Dey, et al.
Molecular Therapy — Oncolytics (2018) Vol. 12, pp. 173-194
Open Access | Times Cited: 204
Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy
Haijie Han, Yi Hou, Xiaohong Chen, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 10, pp. 4944-4954
Closed Access | Times Cited: 195
Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery
Rebekah Omarkhail Elliott, Mei He
Pharmaceutics (2021) Vol. 13, Iss. 1, pp. 122-122
Open Access | Times Cited: 179
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
Daniel R. Principe, Patrick W. Underwood, Murray Korc, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 157
Circulating tumor cells: from new biological insights to clinical practice
Xuyu Gu, Shiyou Wei, Xin Lv
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
HALO-109–301: a Phase III trial of PEGPH20 (with Pemcitabine and Nab-Paclitaxel) in Hyaluronic Acid-High Stage IV Pancreatic Cancer
Gary J. Doherty, Margaret A. Tempero, Pippa Corrie
Future Oncology (2017) Vol. 14, Iss. 1, pp. 13-22
Closed Access | Times Cited: 136
Targeting Pancreatic Stellate Cells in Cancer
Jonas Schnittert, Ruchi Bansal, Jai Prakash
Trends in cancer (2019) Vol. 5, Iss. 2, pp. 128-142
Open Access | Times Cited: 118
Overcoming key biological barriers to cancer drug delivery and efficacy
Susy M. Kim, Peggy H. Faix, Jan E. Schnitzer
Journal of Controlled Release (2017) Vol. 267, pp. 15-30
Open Access | Times Cited: 116
Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma
Hung‐Yi Liu, Murray Korc, Chien‐Chi Lin
Biomaterials (2018) Vol. 160, pp. 24-36
Open Access | Times Cited: 115
Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance
Simona Dalin, Mark R. Sullivan, Allison N. Lau, et al.
Cancer Research (2019) Vol. 79, Iss. 22, pp. 5723-5733
Open Access | Times Cited: 113
Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment
Xiaohong Chen, Fan Jia, Yongzhou Li, et al.
Biomaterials (2020) Vol. 246, pp. 119999-119999
Closed Access | Times Cited: 92
Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle
Xingli Cun, Jiantao Chen, Mengmeng Li, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 43, pp. 39545-39559
Closed Access | Times Cited: 85
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 125-125
Open Access | Times Cited: 82
The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options
Benedetta Ferrara, Cataldo Pignatelli, Mélissande Cossutta, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4442-4442
Open Access | Times Cited: 79
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Bolun Jiang, Li Zhou, Jun Lü, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 72
Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles
Qianwen Yu, Xian Tang, Wei Zhao, et al.
Acta Biomaterialia (2021) Vol. 133, pp. 244-256
Closed Access | Times Cited: 72
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum, Juan L. Vivero‐Escoto
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114357-114357
Open Access | Times Cited: 40
Recent progress in nitric oxide-generating nanomedicine for cancer therapy
Yuce Li, Been Yoon, Anup Dey, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 179-198
Closed Access | Times Cited: 39
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 32
Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue
Yoshimi Arima, Satoko Matsueda, Hideyuki Saya
Cancers (2023) Vol. 15, Iss. 9, pp. 2536-2536
Open Access | Times Cited: 25
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Anna Linehan, Mary O’Reilly, Ray McDermott, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 14
Targeted Therapies for Pancreatic Cancer
Idoroenyi Amanam, Vincent Chung
Cancers (2018) Vol. 10, Iss. 2, pp. 36-36
Open Access | Times Cited: 81
Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
Huan Meng, André E. Nel
Advanced Drug Delivery Reviews (2018) Vol. 130, pp. 50-57
Open Access | Times Cited: 78
The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
Kelly J. Lafaro, Laleh G. Melstrom
American Journal Of Pathology (2018) Vol. 189, Iss. 1, pp. 44-57
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top